MedTrace Logo

Gastroesophageal Reflux Disease Prospective Registry

NCT02479438 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 744

Last updated 2025-05-22

No results posted yet for this study

Summary

The purpose of this registry is to evaluate information to determine which operations and treatments for gastroesophageal reflux disease or similar diseases of the stomach, esophagus or digestive tract are providing the most benefit including the long-term effects of treatment (or no treatment) and the progression of the disease over time.

Conditions

  • GERD

Interventions

OTHER

Diagnosed with GERD

Recording of patient outcomes

Sponsors & Collaborators

  • Baylor Research Institute

    lead OTHER

Principal Investigators

  • Steven Leeds, MD · Baylor Health Care System

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2024-09-30
Completion
2024-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02479438 on ClinicalTrials.gov